Page last updated: 2024-08-26

artenimol and Cruveilhier-Baumgarten Syndrome

artenimol has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, C; Shao, J; Xu, W; Yao, S; Zhang, F; Zheng, S1

Other Studies

1 other study(ies) available for artenimol and Cruveilhier-Baumgarten Syndrome

ArticleYear
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
    The FEBS journal, 2017, Volume: 284, Issue:1

    Topics: Animals; Artemisinins; Carbon Tetrachloride; Cell Death; Chenodeoxycholic Acid; Gene Expression; Hepatic Stellate Cells; Hepatocytes; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Mice, Transgenic; Portal Vein; Pregnenediones; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear

2017